When large incumbents leave significant but challenging markets, leaner startups can leverage new technologies to drive change. As big pharmaceutical companies shy away from neurological disease research, Verge Genomics founder and CEO Alice Zhang describes how a confluence of technological advances in genomics is creating new opportunities. New nontraditional biotech companies, she observes, are being built by multidisciplinary teams fluent in both biology and computer science.
Related
Sam Altman,
OpenAI
The Possibilities of AI [Entire Talk]
AI opportunities are just beginning. The future holds risks and rewards.
Video
46 minutes
Sam Altman,
OpenAI
The Possibilities of AI [Entire Talk]
AI opportunities are just beginning. The future holds risks and rewards.
Qasar Younis,
Applied Intuition
Radically Pragmatic Insights [Entire Talk]
Becoming a successful entrepreneur requires more than ambition.
Video
45 minutes
Qasar Younis,
Applied Intuition
Radically Pragmatic Insights [Entire Talk]
Becoming a successful entrepreneur requires more than ambition.
Sharon Prince,
Grace Farms Foundation
Designing From Values [Entire Talk]
A space is an expression of values, from the earliest concepts to the actual materials.
Video
51 minutes
Sharon Prince,
Grace Farms Foundation
Designing From Values [Entire Talk]
A space is an expression of values, from the earliest concepts to the actual materials.